# Nanopharm (Nanopharm Limited)

Private limited company registered in Leeds, classed under “Manufacture of pharmaceutical preparations”.

- Company number: 04371441
- Status: Active
- Type: Private limited company
- Incorporated: 11 February 2002
- Registered office: 5 Bruntcliffe Avenue, Morley, Leeds, LS27 0LL
- Location: Leeds
- Activity: Manufacture of pharmaceutical preparations

## Latest filed profit

Profit after tax in the year to 31 December 2025: **loss of £1.24m**, from its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Nanopharm do?

Private limited company registered in Leeds, classed under “Manufacture of pharmaceutical preparations”.

### How much turnover does Nanopharm make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/nanopharm-04371441

### Is Nanopharm profitable?

No: it made a loss after tax of £1.24m in the year to 31 December 2025, its latest filed accounts.

### How many people work at Nanopharm?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/nanopharm-04371441

### Who runs and owns Nanopharm?

Its directors are Douglas John Pearson, Guillaume Brouet, Gemma Louise Budd, Douglas John Pearson. Its owners are shown to subscribers.

### Where is Nanopharm based?

Its registered office is 5 Bruntcliffe Avenue, Morley, Leeds, LS27 0LL, in Leeds.

### When was Nanopharm founded?

Nanopharm Limited was incorporated on 11 February 2002.

### Is Nanopharm still trading?

The register lists Nanopharm Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-09-29: Appointment of Mr Douglas John Pearson as a director on 21 September 2026
- 2026-09-24: Full accounts made up to 31 December 2025
- 2026-06-19: Termination of appointment of Gwenaelle Rowe-Joseph as a director on 15 June 2026
- 2025-11-10: Director's details changed for Gwenaelle Rowe-Joseph on 9 November 2025
- 2025-10-20: Appointment of Ms Gemma Louise Budd as a director on 25 September 2025
- 2025-09-29: Accounts for a medium company made up to 31 December 2024
- 2025-07-22: Termination of appointment of Christopher Maxwell Hall as a director on 21 July 2025
- 2024-09-29: Full accounts made up to 31 December 2023
- 2023-11-22: Termination of appointment of Robert Price as a director on 20 November 2023
- 2023-09-29: Accounts for a small company made up to 31 December 2022
- 2022-12-16: Register(s) moved to registered inspection location
- 2022-12-16: Register inspection address has been changed
- 2022-08-26: Accounts for a small company made up to 31 December 2021
- 2022-07-19: Termination of appointment of Jagdeep Singh Shur as a director on 5 July 2022
- 2021-07-01: Accounts for a small company made up to 31 December 2020
- 2020-09-16: Accounts for a small company made up to 31 December 2019
- 2020-04-28: Memorandum and Articles of Association
- 2020-04-28: Resolutions (and 1 more like it since 13 May 2019)
- 2020-03-04: Accounts for a small company made up to 4 June 2019
- 2019-09-13: Current accounting period shortened from 4 June 2020 to 31 December 2019
- 2019-09-12: Previous accounting period shortened from 31 December 2019 to 4 June 2019
- 2019-06-19: Registered office address changed from Fiveways 57-59 Hatfield Road Potters Bar Hertfordshire EN6 1HS England to 5 Bruntcliffe Avenue Morley Leeds LS27 0LL on 19 June 2019
- 2019-06-13: Cessation of Silures Limited as a person with significant control on 5 June 2019
- 2019-06-13: Notification of Aptargroup Uk Holdings Limited as a person with significant control on 5 June 2019
- 2019-06-13: Cessation of Jagdeep Singh Shur as a person with significant control on 5 June 2019

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/nanopharm-04371441